Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02649556 · ClinicalTrials.gov registry record · NA
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
A NA study of Smoking, sponsored by Philip Morris Products S.A..
- Completed
- Registry status
- NA
- Development phase
- 672
- Enrollment target
- 19
- Study locations
NCT02649556: Completed NA study of Smoking, sponsored by Philip Morris Products S.A..
NCT02649556 is a NA study of Smoking that has completed, run by Philip Morris Products S.A.. The registered enrollment target is 672 participants, above the 450-participant average among 123 other Smoking trials with a reported enrollment target (49% higher). The trial reports 19 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02649556, a NA study of Smoking, has completed, sponsored by Philip Morris Products S.A..
- COMPLETED
- Registry status
- NA
- Development phase
- 672 participants
- Enrollment target
- 19
- Study locations
Study Summary
The objective of the ZRHR-ERS-09-EXT-US study is to further assess the effect of the Tobacco Heating System 2.2 (THS 2.2), a candidate Modified Risk Tobacco Product, compared to conventional cigarettes (CC) on the components of the "smokers' health profile" for a prolonged period of 26 weeks, providing additional information to the results of the original study ZRHR-ERS-09-US of 26-week exposure (NCT02396381). In total, the ZRHR-ERS-09-EXT-US study will extend the exposure period to 52 weeks.
Primary Outcome
Concentrations (mg/dL) measured in serum. Mean values are provided as descriptive statistics.
Conditions Studied
Interventions
- OTHER CC
- OTHER THS 2.2
Study Locations (19)
Florida
- Clinical Research West Florida - Clearwater
- Covance, Inc - Daytona Beach
- Compass Research - Orlando
- Clinical Research West Florida - Tampa
- Compass Research - The Villages
North Carolina
- PMG Research of Cary - Cary
- PMG Research of Charlotte - Charlotte
- PMG Research of Raleigh - Raleigh
- PMG Research of Wilmington - Wilmington
Texas
- Benchmark - Austin
- Benchmark - Fort Worth
- Benchmark - San Angelo
Tennessee
- PMG Research of Bristol - Bristol
- NOCCR - Knoxville
Arizona
- Celerion Arizona - Tempe
Kentucky
- Central Kentucky Research Associate - Lexington
Nebraska
- Celerion Lincoln - Lincoln
Ohio
- Midwest Clinical Research - Dayton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 672 participants |
| Start Date | 2015-09-30 |
| Est. Completion | 2017-12-20 |
| Phase | NA |
What the finished NCT02649556 record still lists
NCT02649556 is an interventional study that assigns participants to a tested intervention. The registered 672 participants enrollment target is mid-sized for trials with a published cap, above the 450-participant average among 123 other Smoking trials with a reported enrollment target (49% higher).
The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 2 interventions - of which CC is the first listed.
NCT02649556 lists 19 locations in 9 states (Florida, North Carolina, Texas).
Frequently Asked Questions
What is clinical trial NCT02649556 about?
NCT02649556 is a clinical study titled "A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2". The objective of the ZRHR-ERS-09-EXT-US study is to further assess the effect of the Tobacco Heating System 2.2 (THS 2.2), a candidate Modified Risk Tobacco Product, compared to conventional cigarettes (CC) on the components of the "smokers' health profile" for a prolonged period of 26 weeks, provid...
What is the current status of trial NCT02649556?
This trial is currently completed. It is a NA study. The enrollment target is 672 participants. The study started on 2015-09-30. Estimated completion is 2017-12-20.
What conditions does trial NCT02649556 study?
This clinical trial studies the following conditions: Smoking.
What interventions are being tested in trial NCT02649556?
The interventions under investigation include: CC (OTHER), THS 2.2 (OTHER).
Who is sponsoring clinical trial NCT02649556?
This trial is sponsored by Philip Morris Products S.A., which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02649556 being conducted?
This trial has 19 study locations across Arizona, Florida, Kentucky, Nebraska, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02649556's enrollment target sits among peer trials
672 24th of 123 higher than 100 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
RECRUITING · NA
-
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
RECRUITING · NA
-
Take A Break - Rural
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452031 · 672 participants · NA
A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers
- NCT05493254 · 672 participants · NA
Enhancing Smoking Cessation Via Telehealth Options in Primary Care
- NCT06651086 · 672 participants · NA
Hybrid Effectiveness-Implementation Trial of an Executive Functioning Intervention for Children's Mental Health Services
- NCT07184944 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI